Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

THROMBATE III DIN 02189135

Status: Approved
Holder: GRIFOLS THERAPEUTICS LLC
Molecule: ANTITHROMBIN III (HUMAN)

Health Canada record

Active ingredient(s)ANTITHROMBIN III (HUMAN) 500 UNIT
Dosage formPowder For Solution
RouteIntravenous
ScheduleSCHEDULE D
ClassHuman
ATCB01AB02 ANTITHROMBIN
Original market date
Current status date30-Jan-2012
SourceHealth Canada DPD

Establishment licence of the holder

Grifols Therapeutics LLC — licence , not currently licensed, last inspection rating C (2023-06-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ANTITHROMBIN III (HUMAN)

DINProductCompanyFormStrengthStatus
02237810ANTITHROMBIN III NFTAKEDA CANADA INCPowder For Solution; KitANTITHROMBIN III (HUMAN) 1100 UNITMarketed
02237811ANTITHROMBIN III NFTAKEDA CANADA INCKit; Powder For SolutionANTITHROMBIN III (HUMAN) 550 UNITMarketed
02237812ANTITHROMBIN III IMMUNOBAXTER AGPowder For SolutionANTITHROMBIN III (HUMAN) 1650 UNIT; WATER 30 MLCancelled Post Market
02189143THROMBATE IIIGRIFOLS THERAPEUTICS LLCPowder For SolutionANTITHROMBIN III (HUMAN) 1000 UNITCancelled Post Market
02020572THROMBATE III PWS IV 1000IU/VIALMILES INC. - PHARMACEUTICAL DIVISIONPowder For SolutionANTITHROMBIN III (HUMAN) 1000 UNITCancelled Post Market
02020580THROMBATE III PWS IV 500IU/VIALMILES INC. - PHARMACEUTICAL DIVISIONPowder For SolutionANTITHROMBIN III (HUMAN) 500 UNITCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
129842012-01-30New Drug Submission (NDS)Manufacturer name change
70822005-06-08New Drug Submission (NDS)MANUFACTURER NAME CHANGE
48141995-11-29New Drug Submission (NDS)CHANGE IN MANUFACTURER'S NAME, CHANGE TO THE LABELLING AND PRODUCT MONOGRAPH
Request a quote for THROMBATE III

How to read a Canadian DIN record